EAACI Congress 2025
BackTPS65 - Immune deficiencies and autoimmunity 03
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
D3.329
5.5 Years of Long-Term Efficacy of Oral Berotralstat-LTP in Hereditary Angioedema Patients
D3.326
A RARE COEXISTENCE: CARD9 DEFICIENCY AND IgG4-RELATED DISEASE IN A PEDIATRIC PATIENT
D3.322
Acquired chronic granulomatous disease secondary to myelodysplastic disorder
D3.331
Changes in the attacks’s frequency during Lanadelumab treatment in patients with hereditary angioedema from Romania
D3.332
Determination of Reference Intervals for IgG, IgA, and IgM Levels by Age in Healthy Adults
D3.319
Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema due to C1 Inhibitor Deficiency
D3.318
Difficult diagnosis of rare XMEN primary immunodeficiency syndrome
D3.325
Gene Testing in a Cohort of Patients with Hypogammaglobulinaemia: Experience from a Singaporean Centre for Adults
D3.324
Mastoiditis as complication of Hyper IgM syndrome
D3.317
Moderate-to-severe infections and initial SELENA-SLEDAI correlate with the incidence of flares in patients with Systemic Lupus Erythematosus
D3.328
Relapsing COVID-19 pneumonia and Helicobacter cineadi cellulitis in a patient with X-linked agammaglobulinemia
D3.327
Use of C1 Inhibitor Subcutaneously in the United Kingdom
